Margaret Gates Kuliszewski

Margaret Gates Kuliszewski

Auto-generated profile, based on publicly available information

Margaret Gates Kuliszewski

New York State Department of Health

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2007 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MGMargaret A. Gates
Margaret A. Gates
STShelley S Tworoger
Shelley S Tworoger
JHJonathan L. Hecht
Jonathan L. Hecht
IVImmaculata De Vivo
Immaculata De Vivo
BRBernard Rosner
Bernard Rosner
SHSusan E. Hankinson
Susan E. Hankinson

1 January 2012 in Psychological Services
Verified
Journal Article
Closed access
MGMargaret A. Gates
Margaret A. Gates
DHDarren W. Holowka
Darren W. Holowka
JVJennifer J. Vasterling
Jennifer J. Vasterling
TKTerence M. Keane
Terence M. Keane
BMBrian P. Marx
Brian P. Marx
RRRaymond C. Rosen
Raymond C. Rosen
Posttraumatic stress disorder (PTSD) is a psychiatric disorder that affects 7-8% of the general U.S. population at some point during their lifetime; however, the prevalence is much higher among certain subgroups, including active duty military personnel and veterans. In this article, we review the empirical literature on the epidemiology and screening of PTSD in military and veteran populations, including the availability of sensitive and reliable screening tools. Although estimates vary across studies, evidence suggests that the prevalence of PTSD in deployed U.S. military personnel may be as high as 14-16%. Prior studies have identified trauma characteristics and pre- and posttrauma factors that increase risk of PTSD among veterans and military personnel. This information may help to inform prevention and screening efforts, as screening programs could be targeted to high-risk populations. Large-scale screening efforts have recently been implemented by the U.S. Departments of Defense and Veterans Affairs. Given the prevalence and potential consequences of PTSD among veterans and active duty military personnel, development and continued evaluation of effective screening methods is an important public health need.

12 November 2009 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MGMargaret A. Gates
Margaret A. Gates
BRBernard A. Rosner
Bernard A. Rosner
JHJonathan L. Hecht
Jonathan L. Hecht
STShelley S Tworoger
Shelley S Tworoger
Previous epidemiologic studies suggest that the major histologic subtypes of epithelial ovarian cancer may have different risk factor profiles; however, no known prospective study has systematically examined differences in risk by subtype. The authors used Cox proportional hazards regression, stratified by histologic subtype and time period, to examine the association between ovarian cancer risk factors and incidence of serous invasive, endometrioid, and mucinous ovarian cancers in the US Nurses’ Health Study (1976–2006) and Nurses’ Health Study II (1989–2005). For each exposure, they calculated P-heterogeneity using a likelihood ratio test comparing models with separate estimates for the 3 subtypes versus a single estimate across subtypes. Analysis included 221,866 women and 721 cases with the histologies of interest (496 serous invasive, 139 endometrioid, 86 mucinous). In analyses of reproductive/hormonal exposures, the associations with age, duration of breastfeeding, age at natural menopause, and duration of estrogen use differed significantly by subtype (all P-heterogeneity ≤0.05). The associations with several nonreproductive exposures also appeared to vary by subtype, but only the association with smoking differed significantly (P-heterogeneity = 0.03). Results suggest that associations with several ovarian cancer risk factors vary by subtype, and these differences are consistent with known similarities between each major histologic subtype and its normal tissue counterpart.

23 November 2010 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
MGMargaret A. Gates
Margaret A. Gates
BWBrian M. Wolpin
Brian M. Wolpin
DCDaniel W. Cramer
Daniel W. Cramer
SHSusan E. Hankinson
Susan E. Hankinson
STShelley S Tworoger
Shelley S Tworoger
Previous studies have observed an association between ABO blood group and risk of certain malignancies, including ovarian cancer; however, no prospective studies of the association with ovarian cancer risk are available. Using data from 49,153 women in the Nurses' Health Study, we examined the association between ABO blood group and incidence of epithelial ovarian cancer. Study participants reported their blood type and Rh factor in 1996, and 234 women were diagnosed with incident ovarian cancer during 10 years of follow‐up. We used Cox proportional hazards regression to model the incidence rate ratios (RR) and 95% confidence intervals (CI) of ovarian cancer for each blood group category. Compared to women with blood group O, women with blood group AB or B had a nonsignificant 38% increase in ovarian cancer incidence (95% CI = 0.88–2.16 for blood group AB and 0.96–1.99 for blood group B), whereas blood group A was not associated with risk (RR = 0.95, 95% CI = 0.70–1.30). Combining blood groups AB and B, we observed a statistically significant positive association with presence versus absence of the B antigen overall (RR = 1.41, 95% CI = 1.06–1.88) and for the serous invasive subtype (RR = 1.53, 95% CI = 1.08–2.17). In this large, prospective cohort of women, presence of the B antigen was positively associated with ovarian cancer incidence, whereas blood group A was not associated with risk. Additional studies are needed to confirm this association and to explore the mechanisms through which blood group may influence ovarian cancer risk.

12 February 2009 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
MGMargaret A. Gates
Margaret A. Gates
AVAllison F. Vitonis
Allison F. Vitonis
STShelley S Tworoger
Shelley S Tworoger
BRBernard Rosner
Bernard Rosner
LTLinda Titus‐Ernstoff
Linda Titus‐Ernstoff
DCDaniel W. Cramer
Daniel W. Cramer
Several recent studies have evaluated the association between dietary flavonoid intake and ovarian cancer risk, and all reported significant or suggestive inverse associations with certain flavonoids or flavonoid subclasses; however, most of these studies were small to moderate in size. We, therefore, examined this association in a large, population‐based case‐control study. We calculated intake of 5 common dietary flavonoids (myricetin, kaempferol, quercetin, luteolin, and apigenin), as well as total intake of these flavonoids, for 1,141 cases and 1,183 frequency‐matched controls. We used unconditional logistic regression to estimate the relative risk (RR) of ovarian cancer for each quintile of flavonoid intake when compared with the lowest quintile. We did not observe an association between total flavonoid intake and ovarian cancer risk. The multivariable‐adjusted RR for the highest versus lowest quintile of total flavonoid intake was 1.06 (95% confidence interval [CI] = 0.78–1.45). In analyses of each individual flavonoid, only intake of apigenin was associated with a borderline significant decrease in risk (RR, highest vs. lowest quintile = 0.79, 95% CI = 0.59–1.06; p‐trend = 0.26), and this association was significant after adjustment for intake of the other 4 individual flavonoids (comparable RR = 0.72, 95% CI = 0.53–0.98; p‐trend = 0.09). These results provide limited support for an association between flavonoid intake and ovarian cancer risk. However, given the findings of previous studies and the biologic plausibility of this association, additional studies are warranted.

22 January 2008 in Cancer
Verified
Journal Article
Open access
PDF file
STShelley S Tworoger
Shelley S Tworoger
DGDorota M. Gertig
Dorota M. Gertig
MGMargaret A. Gates
Margaret A. Gates
JHJonathan L. Hecht
Jonathan L. Hecht
SHSusan E. Hankinson
Susan E. Hankinson
BACKGROUND: Smoking, caffeine, and alcohol intake are all potentially modifiable factors that have an unclear association with ovarian cancer risk. Therefore, the associations between these exposures and ovarian cancer risk were prospectively examined among 110,454 women in the Nurses' Health Study (NHS) for the smoking analyses and 80,253 women for the dietary analyses.METHODS: Women completed biennial questionnaires assessing ovarian cancer risk factors beginning in 1976, with food frequency questionnaires administered every 2 to 4 years starting in 1980. For the smoking analyses, 737 confirmed cases of epithelial ovarian cancer were identified and for the dietary aims, 507 cases were identified through June 1, 2004.RESULTS: Compared with never‐smokers, neither current nor past smoking was associated with ovarian cancer risk overall; however, both were associated with mucinous tumors (n = 69; rate ratio [RR], past = 2.02 [95% confidence interval (CI), 1.15–3.55]; RR, current = 2.22 [95% CI, 1.16–4.24]). A modest inverse association between caffeine intake and ovarian cancer risk was observed (RR, top vs bottom quintile = 0.80; 95% CI, 0.60–1.07 [P = .03]), which was strongest for women who had never used either oral contraceptives (RR = 0.65; 95% CI, 0.46–0.92 [P for heterogeneity = .02]) or postmenopausal hormones (RR = 0.57; 95% CI, 0.36–0.91 [P for heterogeneity = .13]). Alcohol was not associated with ovarian cancer risk.CONCLUSIONS: The results of the current study suggest that cigarette smoking may only increase the risk for mucinous ovarian tumors, and alcohol intake was not associated with risk. However, an inverse association was observed between caffeine intake and ovarian cancer risk, particularly in women not using hormones; this finding merits further study. Cancer 2008. © 2008 American Cancer Society.